Peak6 Investments LLC Axonics, Inc. Call Options Transaction History

Peak6 Investments LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 14, 2024	SELL	$56.67 - $69.36 $1.55 Million - $1.9 Million	-27,400 Reduced 63.13%	16,000 $1.1 Million
Q4 2023 Feb 13, 2024	BUY	$49.38 - $63.75 $824,646 - $1.06 Million	16,700 Added 62.55%	43,400 $2.7 Million
Q3 2023 Nov 13, 2023	BUY	$48.64 - $62.51 $1.3 Million - $1.67 Million	26,700 New	26,700 $1.5 Million
Q2 2022 Aug 12, 2022	SELL	$39.5 - $64.42 $146,150 - $238,354	-3,700 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$43.74 - $62.76 $104,976 - $150,624	2,400 Added 184.62%	3,700 $232,000
Q3 2021 Nov 12, 2021	SELL	$59.21 - $78.66 $5,921 - $7,866	-100 Reduced 7.14%	1,300 $85,000
Q2 2021 Aug 13, 2021	SELL	$51.39 - $66.9 $318,618 - $414,780	-6,200 Reduced 81.58%	1,400 $89,000
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $320,644 - $391,400	7,600 New	7,600 $379,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.